Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and RussiaGordon Cook, María‐Victoria Mateos, Alessandro Corso et al.|Oncology and Therapy|2021Cited by 9
PS1425 RESULTS OF THE DARATUMUMAB MONOTHERAPY EARLY ACCESS TREATMENT PROTOCOL (EAP) IN PATIENTS FROM EUROPE AND RUSSIA WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMAGary Cook, María‐Victoria Mateos, Alessandro Corso et al.|HemaSphere|2019Cited by 3
Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid LeukemiaJG Kuiper, Maren Gaudig, P. Musingarimi et al.|Value in Health|2015Cited by 0